Comparison of dyskinesia profiles after L-DOPA dose challenges with or without dopamine agonist coadministration
Open Access
- 12 June 2023
- journal article
- research article
- Published by Elsevier in Neuropharmacology
- Vol. 237, 109630
Abstract
No abstract availableKeywords
Funding Information
- Swedish Research Council (2020-02696)
- National Institutes of Health
- Lunds Universitet
- Lundbeck Foundation (R336-2020-1035)
This publication has 44 references indexed in Scilit:
- Meta‐analysis of the comparative efficacy and safety of adjuvant treatment to levodopa in later Parkinson's diseaseMovement Disorders, 2011
- The Physiology, Signaling, and Pharmacology of Dopamine ReceptorsPharmacological Reviews, 2011
- Dopamine D3 receptor stimulation underlies the development of L-DOPA-induced dyskinesia in animal models of Parkinson's diseaseNeurobiology of Disease, 2009
- Evaluation of D2 and D3 dopamine receptor selective compounds on l-dopa-dependent abnormal involuntary movements in ratsNeuropharmacology, 2009
- The Unified Dyskinesia Rating Scale: Presentation and clinimetric profileMovement Disorders, 2008
- Development of dyskinesias in a 5‐year trial of ropinirole and L‐dopaMovement Disorders, 2006
- Motor fluctuations and dyskinesias in Parkinson's disease: Clinical manifestationsMovement Disorders, 2005
- Clinical Pharmacokinetic and Pharmacodynamic Properties of Drugs Used in the Treatment of Parkinson??s DiseaseClinical Pharmacokinetics, 2002
- Utility of an objective dyskinesia rating scale for Parkinson's disease: Inter‐ and intrarater reliability assessmentMovement Disorders, 1994
- Buspirone in the treatment of levodopa induced dyskinesias.Journal of Neurology, Neurosurgery & Psychiatry, 1991